Page: PRIME: priority medicines-2025/9/26

Document: Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 15-18 September 2025-2025/9/26

Document: List of medicines currently in PRIME scheme-2025/9/26

Page: Innovation Task Force briefing meetings-2025/9/25

Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)-2025/9/25

Page: Medicine Shortages Single Point of Contact (SPOC) Working Party-2025/9/25

Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025-2025/9/25

Page: Product-specific bioequivalence guidance-2025/9/25

Document: Eltrombopag film-coated tablets 12.5 mg, 25 mg, 50 mg, 75 mg and powder for oral suspension 25 mg product-specific bioequivalence guidance-2025/9/25

Document: Melatonin prolonged release tablets 2 mg product-specific bioequivalence guidance-2025/9/25